Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Polycystic Ovary Syndrome 18Carcinoma, Non-Small-Cell Lung 14Colorectal Neoplasms 11Lung Neoplasms 9Recurrence 7Neoplasm Metastasis 5Colonic Neoplasms 5Breast Neoplasms 5Rectal Neoplasms 4Ovarian Neoplasms 4Lymphoma, T-Cell, Peripheral 4Infertility 4Neoplasms 3Lymphoma, T-Cell 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Sezary Syndrome 2Papillomavirus Infections 2Mycosis Fungoides 2Meningeal Carcinomatosis 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, B-Cell 2Lymphoma 2Insulin Resistance 2Infertility, Female 2Hyperandrogenism 2Head and Neck Neoplasms 2Diabetes, Gestational 2Carcinoma, Transitional Cell 2Atypical Squamous Cells of the Cervix 2

Interventions

Vitamin B Complex 1Folic Acid 1Carnitine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hyperbilirubinemia × Folic Acid × Clear all
NCT03564678 2025-09-05

Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia

M.D. Anderson Cancer Center

Phase 2 Terminated
10 enrolled 5 charts
LymphoidOther hematologic neoplasm

Hyperbilirubinemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡